- Health at Bayer
Treatments & Therapies
- Chronic Kidney Disease
- Eye Conditions
- Healthy Aging
- Hormonal & Reproductive Health
Innovation & Technologies
- Patient Access Charter
- Leadership Perspective
- Strengthening Healthcare Access
- Empowering Women, Globally
- Fighting Neglected Tropical Diseases
- Moving Non-Communicable Diseases Care Forward
- Ensuring a Sustainable Product Supply
- Delivering Better Cancer Care
- News & Stories
- Clinical Trials Explorer
- Transparency Policy
- Treatments & Therapies
- Our Commitments
- Report a Side Effect
- Medical Counterfeits
We put patients first. People living with a disease inspire and motivate us to create healthcare solutions together for a better life.
37.2 trillion cells, 3.2 billion base pairs of DNA, 19,000 genes encoding proteins, 2,000 active proteins functioning within a cell, 10 million chemical reactions per second in every cell across 70 organs1 - the human body is complex and every patient is unique. All of us respond to medicines in different ways, so the best drug for one patient may have the potential for side effects in another. Patient safety is our number one priority. It is more than just an obligation; it is our commitment to good medicine.
We have a comprehensive Pharmacovigilance process which constantly monitors drugs and devices throughout their whole lifecycle as well as the effect they have on patients. Bayer has over 1,000 pharmacovigilance experts who analyze side effects and develop measures to minimize or even prevent them. In a nutshell, they constantly keep an eye on the safety of patients who use our products.
It takes around 10 to 12 years and costs over one billion Euros to research and develop a new drug. Scientists study how well a drug works (efficacy), tolerability and safety of a new medicine in their effort to bring new treatment options to patients. In order for a new treatment to be approved, the drug has to show its benefits are greater than its risks.
The benefits and risks are continuously assessed for as long as the drug is on the market. We also rely on individual feedback as to how the drug is performing from both doctors and patients.
Who can contribute to patient safety and how?
Regulates clinical trials of medicines and medical devices. Assesses clinical data and authorizes medicinal products for sale. Post-marketing surveillance for monitoring and reporting of adverse events. Promotes safe use of medicines and devices and ensures compliance with statutory obligations.
Develops risk management plans and risk minimization measures for medicines and treatments. Constantly monitors benefit-risk profiles of drugs and ensures information leaflets are updated.
Shares important information on medical history or other treatments. Reports suspected side effects when using medicinal products or devices which helps to improve patient safety.
Weighs up benefits and risks of available treatments for each patient. Prescribes medicinal products and devices. Monitors and manages reports of suspected side effects. If confirmed, the healthcare professional reports the suspected side effect to the authorities.
1 SAP, Performance Databases - www.brmassocllc-org.com/Singh_20150608_HighPerformanceDB.pptx Last accessed May 2018